First comparison between Multicolor Flow Cytometry and droplet digital PCR for tumor burden quantification at baseline in mantle cell lymphoma by Drandi, Daniela et al.
Politecnico di Torino
Porto Institutional Repository
[Proceeding] First comparison between Multicolor Flow Cytometry and
droplet digital PCR for tumor burden quantification at baseline in mantle cell
lymphoma
Original Citation:
Drandi, Daniela; Jimenez,Cristina; Monitillo, Luigia;Barbero,Daniela; Ruggeri, Marina; Mantoan,B;
Genuardi,Elisa; Gilestro,Milena ; Zaccaria,Gian Maria; Ghione,Paola; Vasta,M; Loschirico,M;
Omedè,Paola ; Cavallo,Federica;Cortelazzo, Sergio;Boccadoro, Mario ; García-Sanz,R; Ladetto
Marco; Ferrero Simone (2016). First comparison between Multicolor Flow Cytometry and droplet
digital PCR for tumor burden quantification at baseline in mantle cell lymphoma. In: 5th ESLHO
symposium, Prague. pp. 82-83
Availability:
This version is available at : http://porto.polito.it/2662554/ since: January 2017
Publisher:
European Scientific Foundation of Laboratory Hemato Oncology
Terms of use:
This article is made available under terms and conditions applicable to Open Access Policy Article
("Public - All rights reserved") , as described at http://porto.polito.it/terms_and_conditions.
html
Porto, the institutional repository of the Politecnico di Torino, is provided by the University Library
and the IT-Services. The aim is to enable open access to all the world. Please share with us how
this access benefits you. Your story matters.
(Article begins on next page)
First comparison between Multicolor Flow Cytometry and droplet digital 
PCR for tumor burden quantification at baseline in mantle cell lymphoma 
D.Drandi1, C.Jimenez2, L.Monitillo1, D.Barbero1, M.Ruggeri1, B.Mantoan1, E.Genuardi1, M. Gilestro3, G.M.Zaccaria4, P.Ghione1, M.Vasta1, M.Lo Schirico1, P.Omedè3, F.Cavallo1, 
S.Cortelazzo5, M.Boccadoro1,3, R.García-Sanz2, M.Ladetto6 and S.Ferrero1
1Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy; 2 Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, Espania; 3Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy; 4Biolab 
at Department of Electronics and Telecommunications (DET), Politecnico di Torino, Italy, , 5Medical Oncology and Hematology Unit, Istituto Clinico Humanitas-Gavazzeni, Bergamo, Italy; 6Division of Hematology, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy 
METHODS
BACKGROUND AND AIMS
RESULTS
CONCLUSIONS
REFERENCES
daniela.drandi@unito.it
simone.ferrero@unito.it The authors declare no conflict of interest.
Quantification of tumor load at diagnosis has been shown to provide an additional prognostic tool, in mature lymphoproliferative disorders [1]. Multiparameter
Flow Cytometry (MFC) is the most commonly used method to assess the degree of tumor infiltration at baseline. However, inter-laboratory standardization still
needs to be fulfilled before MFC can be implemented in multicenter trials. Since droplet digital PCR (ddPCR) represents a feasible alternative, effortless
to standardize and potentially able to overcome some MFC drawbacks, we compared the reliability of ddPCR versus MFC for tumor quantification at
baseline, in a phase III, multicenter clinical trial for mantle cell lymphoma (MCL) patients.
• This study represents the first comparison between MFC and ddPCR, for baseline tumor load quantification in a multicenter MCL trial.
• A moderate correlation (r=0,6) between methods has been observed.
• Accurate guidelines for ddPCR setting and data analysis are required before this tool can be implemented in the clinical practice.
• However, given the high precision, the technical simplicity and the potentiality to be easily standardized, ddPCR might be proposed for
tumor load quantification in those cases lacking reliable MFC and/or qPCR data.
ddPCR was performed on baseline samples of MCL patients enrolled in the Italian “MCL0208” trial (EUdract:2009-012807-25) sponsored by FIL (Fondazione-
Italiana-Linfomi). Quantification of IGH-VDJ by ddPCR was performed with the QX100 ddPCR system (Bio-Rad) as described [2]. The same allele-specific
primers and consensus probes setted up for qPCR were used in ddPCR. 500 ng of gDNA were loaded in triplicate, a negative control (gDNA pooled from 10
healthy donors) and NTC were included. The final tumor load was calculated as the merge of replicates. MFC was performed by a 6-color panel for BM
(K/L/CD19/CD23/CD5) and PB (also CD22/CD20/CD43/CD200) on FACSCantoII (Becton Dickinson) (Fig1). qPCR was based on serial 10-fold dilution
standard curves, starting from 500ng gDNA, using a AbiPrism7900HT (Life Technologies), according to Euro-MRD guidelines [3]. Methods comparison was
assessed using bivariate Pearson’s correlation and results were considered discordant when difference in clonal cells quantification was >=1 log.
MFC versus ddPCR, was performed on 131 baseline samples, 64 Bone Marrow (BM) and 67 Peripheral Blood (PB), from 64 MCL patients. Overall, the
correlation between the two techniques was moderate (r=0,6) and slightly higher for PB samples (r=0,7) (Figure1).
Stratifying the samples based on MFC tumor infiltration (27 low, =<1%, 45 mid, 1-10% and 59 high, 10-100%), Pearson correlation show a better correlation
for samples with MFC>10% (PB r=0,5 and BM r=0,6) compared to samples with low MFC<10% (PB r=0,3, BM r=0,01). Superimposable results with ddPCR
were observed in terms of median of absolute target copies, low: 253 (range 2-27993), mid:1636 (2-66000) and high: 16133 (14-72550), however, the
leukemic nature of MCL was better reflected by ddPCR (PB:7068 copies, range 2-56387, BM:3100 copies; range 4-66000) compared to MFC (PB:6%, range
0,01-92,6; BM:8,7%, range 0,03%-92,1%).
33/131(25%) samples were discordant, not clustering in specific patients or tissues. Notably, 24% of discordances (8/33: 4 low, 3 mid, 1 high tumor infiltration),
showing ddPCR>MFC, were confirmed by qPCR, suggesting a MFC underestimation, probably due to sample shipment modalities in a multicenter trial.
However, in other 24% highly infiltrated samples (8/33: 1 mid, 7 high) qPCR endorsed the MFC results, discrepancy that might be related to the use in qPCR,
and not in ddPCR, of 10 times diluted DNA. It must be speculate that saturation issue of ddPCR reaction could have been affected the reliability of the
quantification, in highly infiltrated samples. Unfortunately, in half of the discordant cases (17/33, 52%, 7 low, 9 mid, 1 high) the qPCR performance was
suboptimal, consequently we cannot rely on qPCR data for further inference (Table1).
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7 (*) and 1 (#)  samples in which qPCR endorses MFC results 

